Last €36.79 EUR
Change Today +0.279 / 0.76%
Volume 0.0
3IP On Other Exchanges
Symbol
Exchange
NASDAQ GS
Berlin
As of 2:16 AM 09/3/14 All times are local (Market data is delayed by at least 15 minutes).

ipc the hospitalist co (3IP) Snapshot

Open
€36.72
Previous Close
€36.51
Day High
€36.79
Day Low
€36.72
52 Week High
12/2/13 - €46.09
52 Week Low
06/19/14 - €27.45
Market Cap
632.5M
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
17.2M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for IPC THE HOSPITALIST CO (3IP)

ipc the hospitalist co (3IP) Related Bloomberg News

View More Bloomberg News

ipc the hospitalist co (3IP) Related Businessweek News

No Related Businessweek News Found

ipc the hospitalist co (3IP) Details

IPC The Hospitalist Company, Inc., through its subsidiaries, provides hospitalist services in the United States. It offers, manages, and coordinates the care of hospitalized patients, as well as serves as the inpatient partner of primary care physicians and specialists. The company also provides administrative and professional services, including information management system, transition management, regional management, recruiting, training, financial reporting, billing and collection, risk management, and compliance services to affiliated hospitalists. As of December 31, 2013, its 1,760 affiliated hospitalists, including physicians, nurse practitioners, and physician assistants provided hospitalist solutions at approximately 410 hospitals, and 1,100 other inpatient and post-acute care facilities primarily in 26 states. IPC The Hospitalist Company, Inc. serves patients, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, and health plans. IPC The Hospitalist Company, Inc. was formerly known as InPatient Consultants Management, Inc. The company was founded in 1995 and is headquartered in North Hollywood, California.

Founded in 1995

ipc the hospitalist co (3IP) Top Compensated Officers

Co-Founder, Chairman, Chief Executive Officer...
Total Annual Compensation: $543.0K
President, Chief Operating Officer, Director ...
Total Annual Compensation: $435.0K
Chief Financial Officer and Corporate Secreta...
Total Annual Compensation: $360.0K
Chief Medical Officer
Total Annual Compensation: $370.0K
Chief Development Officer and Executive Vice ...
Total Annual Compensation: $360.0K
Compensation as of Fiscal Year 2013.

ipc the hospitalist co (3IP) Key Developments

IPC The Hospitalist Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014; Reaffirms Earnings Guidance for the Full Year 2014

IPC The Hospitalist Company, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported net revenue of $172,268,000 compared to $145,753,000 a year ago. Income from operations was $17,576,000 compared to $20,032,000 a year ago. Income before income taxes was $17,195,000 compared to $19,936,000 a year ago. Net income was $10,609,000 or $0.61 per diluted share compared to $12,301,000 or $0.71 per diluted share a year ago. Adjusted EBITDA increased 14.5% to $18.2 million compared with adjusted EBITDA of $15.9 million for the same period in the prior year. The adjusted EBITDA margin decrease of 30 basis points compared with the same period in the prior year is primarily related to an increase in general and administrative expenses as a percentage of revenue. Adjusted net income increased 12.4% to $10.2 million compared with adjusted net income of $9.1 million for the same period in the prior year. Adjusted diluted earnings per share for the three months ended June 30, 2014 and 2013 was $0.58 and $0.53, respectively. For the six months period, the company reported net revenue of $344,994,000 compared to $298,844,000 a year ago. Income from operations was $34,540,000 compared to $37,171,000 a year ago. Income before income taxes was $33,846,000 compared to $36,962,000 a year ago. Net income was $20,883,000 or $1.19 per diluted share compared to $22,806,000 or $1.33 per diluted share a year ago. Net cash provided by operating activities was $26,114,000 compared to $20,531,000 a year ago. Purchase of property and equipment was $2,485,000 compared to $2,136,000 a year ago. The company reaffirmed its guidance for the full year 2014 and expects revenue to be in the range of $720 million to $732 million, an adjusted EBITDA range of $76 million to $79 million, and adjusted diluted earnings per share to be in the range of $2.41 to $2.51. The company has provided this outlook based on assumptions of a 38.3% effective tax rate, $6.0 million in depreciation and amortization expense.

IPC The Hospitalist Company, Inc. Presents at Avondale Partners Healthcare 1-1 Conference, Aug-11-2014

IPC The Hospitalist Company, Inc. Presents at Avondale Partners Healthcare 1-1 Conference, Aug-11-2014 . Venue: Boston Harbor Hotel, Boston, Massachusetts, United States. Speakers: Adam D. Singer, Co-Founder, Chairman, Chief Executive Officer and Member of Quality Committee, Jeff Taylor, president and chief operating officer.

IPC The Hospitalist Company, Inc. to Report Q2, 2014 Results on Jul 23, 2014

IPC The Hospitalist Company, Inc. announced that they will report Q2, 2014 results at 5:00 PM, Eastern Standard Time on Jul 23, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
3IP:GR €36.79 EUR +0.279

3IP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 3IP.
View Industry Companies
 

Industry Analysis

3IP

Industry Average

Valuation 3IP Industry Range
No financial data is available for 3IP.
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IPC THE HOSPITALIST CO, please visit www.hospitalist.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.